As an adipokine, CTRP3 also functions in regulating lipid metabolism, as recombinant CTRP3 treatment regulated hepatic lipid metabolism and displayed therapeutic potential for attenuating hepatic steatosis [24]. Here, C1QTNF3 is linked to fatty liver disease.